Off-label drugs for weight management
Ed J Hendricks Center for Weight Management, Roseville and Sacramento, CA, USA Abstract: The global pandemic of obesity and overweight now affects between 2.8 and 3.5 ­billion of the world population and shows no signs of abatement. Treatment for what is now recognized as a chronic...
Guardado en:
Autor principal: | Hendricks EJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b325cbc5d60492d814e8256cfa35c55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Kwon YJ, et al.
Publicado: (2021) -
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
por: Hurt RT, et al.
Publicado: (2018) -
Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications
por: Gong M, et al.
Publicado: (2020) -
Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
por: Leng W, et al.
Publicado: (2021) -
Research on Approaches for Regulation of the “Off-label” use of Medicinal Products in the European Union
por: Drenska M., et al.
Publicado: (2017)